A recent study determined that patients with asymptomatic SARS-CoV-2 infection had higher values of fibroblast growth factors (including FGF19, FGF21, and FGF23) compared to those with mild symptomatic COVID-19 [18]. The gene discussed is FGF19; the disease is COVID-19.